A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 502,283 shares of TEVA stock, worth $11.1 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
502,283
Previous 503,743 0.29%
Holding current value
$11.1 Million
Previous $8.19 Million 10.58%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.81 - $18.96 $23,082 - $27,681
-1,460 Reduced 0.29%
502,283 $9.05 Million
Q2 2024

Aug 08, 2024

SELL
$12.78 - $17.4 $858,662 - $1.17 Million
-67,188 Reduced 11.77%
503,743 $8.19 Million
Q1 2024

May 10, 2024

SELL
$10.67 - $14.43 $270,751 - $366,161
-25,375 Reduced 4.26%
570,931 $8.06 Million
Q4 2023

Feb 09, 2024

SELL
$8.12 - $10.63 $167,734 - $219,583
-20,657 Reduced 3.35%
596,306 $6.23 Million
Q3 2023

Nov 09, 2023

SELL
$7.48 - $10.7 $114,084 - $163,196
-15,252 Reduced 2.41%
616,963 $6.29 Million
Q2 2023

Aug 08, 2023

SELL
$7.2 - $9.47 $71,373 - $93,876
-9,913 Reduced 1.54%
632,215 $4.76 Million
Q1 2023

May 10, 2023

BUY
$8.36 - $11.37 $130,533 - $177,531
15,614 Added 2.49%
642,128 $5.68 Million
Q4 2022

Feb 10, 2023

BUY
$7.95 - $9.48 $188,804 - $225,140
23,749 Added 3.94%
626,514 $5.71 Million
Q3 2022

Nov 10, 2022

BUY
$6.86 - $11.95 $174,436 - $303,864
25,428 Added 4.4%
602,765 $4.86 Million
Q2 2022

Aug 09, 2022

BUY
$7.38 - $10.4 $703,498 - $991,380
95,325 Added 19.78%
577,337 $4.34 Million
Q1 2022

May 12, 2022

SELL
$7.33 - $9.39 $582,786 - $746,570
-79,507 Reduced 14.16%
482,012 $4.53 Million
Q4 2021

Feb 09, 2022

SELL
$7.9 - $10.19 $2,180 - $2,812
-276 Reduced 0.05%
561,519 $4.5 Million
Q3 2021

Nov 12, 2021

SELL
$8.38 - $10.18 $148,460 - $180,348
-17,716 Reduced 3.06%
561,795 $5.47 Million
Q2 2021

Aug 12, 2021

SELL
$9.9 - $11.56 $554,023 - $646,920
-55,962 Reduced 8.81%
579,511 $5.74 Million
Q1 2021

May 12, 2021

SELL
$10.34 - $12.81 $1.38 Million - $1.71 Million
-133,654 Reduced 17.38%
635,473 $7.32 Million
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $621,254 - $796,591
-72,155 Reduced 8.58%
769,127 $7.42 Million
Q3 2020

Nov 12, 2020

SELL
$8.57 - $12.69 $180,801 - $267,720
-21,097 Reduced 2.45%
841,282 $7.58 Million
Q2 2020

Sep 11, 2020

SELL
$8.12 - $13.12 $609,657 - $985,062
-75,081 Reduced 8.01%
862,379 $10.6 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $1.13 Million - $1.82 Million
138,962 Added 17.4%
937,460 $10.6 Million
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $35,296 - $70,962
5,276 Added 0.67%
798,498 $7.17 Million
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $144,234 - $236,783
-22,088 Reduced 2.71%
793,222 $7.77 Million
Q3 2019

Nov 12, 2019

SELL
$6.16 - $9.6 $152,786 - $238,108
-24,803 Reduced 2.95%
815,310 $5.64 Million
Q2 2019

Aug 07, 2019

BUY
$8.12 - $15.72 $873,833 - $1.69 Million
107,615 Added 14.69%
840,113 $7.63 Million
Q1 2019

May 13, 2019

SELL
$15.58 - $20.01 $29,383 - $37,738
-1,886 Reduced 0.26%
732,498 $11.4 Million
Q4 2018

Feb 12, 2019

SELL
$14.59 - $23.84 $10,840 - $17,713
-743 Reduced 0.1%
734,384 $11.3 Million
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $25.4 Million - $31 Million
-1,208,394 Reduced 62.18%
735,127 $15.8 Million
Q2 2018

Aug 10, 2018

BUY
$16.77 - $24.71 $2.15 Million - $3.17 Million
128,469 Added 7.08%
1,943,521 $47.3 Million
Q1 2018

May 11, 2018

BUY
$16.68 - $22.07 $24,286 - $32,133
1,456 Added 0.08%
1,815,052 $31 Million
Q4 2017

Feb 09, 2018

BUY
$11.23 - $19.1 $60,967 - $103,693
5,429 Added 0.3%
1,813,596 $34.4 Million
Q3 2017

Nov 13, 2017

BUY
$15.41 - $32.17 $27.9 Million - $58.2 Million
1,808,167
1,808,167 $31.8 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.